The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADDEX THERAPEUTICS LTD SPONSORED ADS 00654J107 115 17,418 SH   SOLE   17,418 0 0
CALUMET SPECIALTY PRODS PTNR UT LTD PARTNER 131476103 138 131,204 SH   SOLE   131,204 0 0
CRESCENT CAP BDC INC COM 225655109 332 34,405 SH   SOLE   34,405 0 0
CTI BIOPHARMA CORP COM NEW 12648L601 567 616,695 SH   SOLE   616,695 0 0
EIGER BIOPHARMACEUTICALS INC COM 28249U105 555 81,617 SH   SOLE   81,617 0 0
FS KKR CAPITAL CORP COM 302635107 511 170,332 SH   SOLE   170,332 0 0
GARRISON CAP INC COM 366554103 1,979 1,164,061 SH   SOLE   1,164,061 0 0
GLYCOMIMETICS INC COM 38000Q102 34 15,103 SH   SOLE   15,103 0 0
KALA PHARMACEUTICALS INC COM 483119103 16,141 1,836,313 SH   SOLE   1,836,313 0 0
KURA ONCOLOGY INC COM 50127T109 222 22,302 SH   SOLE   22,302 0 0
MEI PHARMA INC COM NEW 55279B202 1,426 885,560 SH   SOLE   885,560 0 0
MOLECULAR TEMPLATES INC COM 608550109 28,015 2,107,991 SH   SOLE   2,107,991 0 0
SATSUMA PHARMACEUTICALS INC COM 80405P107 13,048 606,320 SH   SOLE   606,320 0 0
SCYNEXIS INC COM 811292101 6,198 7,936,111 SH   SOLE   7,936,111 0 0
SIERRA ONCOLOGY INC COM NEW 82640U404 6,324 643,959 SH   SOLE   643,959 0 0
STRONGBRIDGE BIOPHARMA PLC SHS USD G85347105 12,497 6,612,065 SH   SOLE   6,612,065 0 0
SUNESIS PHARMACEUTICALS INC COM PAR 867328700 3,375 8,134,926 SH   SOLE   8,134,926 0 0